Genomic Strategies Target Bacteria

Bacteria are winning, and infectious disease doctors are worried. Disease-causing microbes are increasingly able to defeat the best antimicrobial drugs available. No "superbug" has yet emerged, resistant to all antibiotics and therefore untreatable. But that day may not be too far off. "There's increasing panic among infectious disease specialists,'' admits Jonathan Blum, a clinician and researcher at Harvard Medical School. Particularly worrisome to those specialists is a strain k

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Bacteria are winning, and infectious disease doctors are worried. Disease-causing microbes are increasingly able to defeat the best antimicrobial drugs available. No "superbug" has yet emerged, resistant to all antibiotics and therefore untreatable. But that day may not be too far off.

"There's increasing panic among infectious disease specialists,'' admits Jonathan Blum, a clinician and researcher at Harvard Medical School.

Particularly worrisome to those specialists is a strain known as methicillin-resistant Staphylococcus aureus (MRSA), which occurs widely in hospitals and is resistant to all antibiotics save one, vancomycin. Staph aureus is a common skin bacterium that can cause deadly infections when it enters the body, such as after surgery. Recently, a few cases of MRSA that show intermediate resistance to vancomycin have appeared. If true resistance develops, Staph aureus infections might be uncurable, and therefore fatal.

As multiply resistant pathogenic microbes become more common, development of antibiotics has lagged behind. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Billy Goodman

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo